Planta Med 2003; 69(10): 910-913
DOI: 10.1055/s-2003-45099
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Effect of Limonin and Nomilin on HIV-1 Replication on Infected Human Mononuclear Cells

Lucia Battinelli1 , Fabio Mengoni2 , Miriam Lichtner2 , Gabriela Mazzanti1 , Antonina Saija3 , Claudio Maria Mastroianni2 , Vincenzo Vullo2
  • 1Department of Pharmacology of Natural Substances and General Physiology, University ”La Sapienza”, Rome, Italy
  • 2Department of Infectious and Tropical Diseases, University ”La Sapienza”, Rome, Italy
  • 3Department Farmaco-Biologico, University of Messina, Messina, Italy
Weitere Informationen

Publikationsverlauf

Received: February 13, 2003

Accepted: July 26, 2003

Publikationsdatum:
02. Dezember 2003 (online)

Preview

Abstract

In the last years several plant-derived natural compounds have been screened for their anti-HIV activity in order to find lead compounds with novel structures or mechanisms of action. Among these, several triterpenoids have been found to exhibit an antiretroviral activity with different mechanisms of action. In this study the effect of two limonoids, limonin and nomilin, on the growth of human immunodeficiency virus-1 (HIV-1) in culture of human peripheral blood mononuclear cells (PBMC) and on monocytes/macrophages (M/M) is described. Limonin and nomilin were found to inhibit the HIV-1 replication in all cellular systems used. A dose-dependent inhibition of viral replication was observed in PBMC isolated from healthy donors and infected with HIV-1 strain after incubation with limonin and nomilin (EC50 values: 60.0 μM and 52.2 μM, respectively). The two terpenoids inhibited at all concentrations studied the production of HIV-p24 antigen even when the PBMC employed were chronically infected (EC50 values of 61.0 μM for limonin and 76.2 μM for nomilin). Moreover, these compounds inhibited the HIV-1 replication even in infected M/M. In this cellular system the inhibitory effect was significant at the concentrations of 20 μM, 40 μM and 80 μM starting from day 14 and reached the maximum effect after 18 days of incubation. As regards the mechanism of action, limonin and nomilin inhibit in vitro HIV-1 protease activity. In general, the results obtained point out a similar anti-HIV activity of limonin and nomilin indicating that this activity is not drastically influenced by the structural difference between the two compounds.

References

Dr. Lucia Battinelli

Department of Pharmacology of Natural Substances and General Physiology

University ”La Sapienza”

Piazzale Aldo Moro 5

00185, Rome

Italy

Telefon: +39 06 49912903

Fax: +39 06 49912480

eMail: lucia.battinelli@uniroma1.it